Memorial Sloan Kettering Cancer Center - Company Profile
Powered by
All the data and insights you need on Memorial Sloan Kettering Cancer Center in one report.
- Save hours of research time and resources with
our up-to-date Memorial Sloan Kettering Cancer Center Strategy Report
- Understand Memorial Sloan Kettering Cancer Center position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Memorial Sloan Kettering Cancer Center Catalyst Calendar
Proactively evaluate Memorial Sloan Kettering Cancer Center’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Memorial Sloan Kettering Cancer Center Catalyst Calendar data
Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
---|---|---|---|---|---|---|---|
01 Dec 2019 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
01 Dec 2019 | Phase I/II Trial Completion | Children's Hospital of Michigan; Memorial Sloan Kettering Cancer Center; National Cancer Institute US; University of Virginia; Wayne State University | - | aldesleukin; Cellular Immunotherapy to Target CD3 and GD2 for Oncology; sargramostim | Oncology | Neuroblastoma; Osteosarcoma; Solid Tumor | Clinical Trial Registry |
30 Nov 2019 | Phase 0 Trial Initiation | AIDS and Cancer Specimen Resource; AIDS Malignancy Clinical Trials Consortium; Emmes Co LLC; Johnson & Johnson; Memorial Sloan Kettering Cancer Center; Montefiore Medical Center; National Cancer Institute US | JNJ | daratumumab | Oncology | Diffuse Large B-Cell Lymphoma; Lymphoma | Clinical Trial Registry |
01 Nov 2019 | Phase I Trial Completion | Adera Labs LLC; Memorial Sloan Kettering Cancer Center | - | capecitabine; disulfiram; docetaxel; FOLFIRINOX [leucovorin + fluorouracil + irinotecan + oxaliplatin]; FOLFOX [leucovorin + fluorouracil + oxaliplatin]; gemcitabine; oxaliplatin; paclitaxel albumin bound | Oncology | Pancreatic Cancer | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer